ReviewGene therapy2007
Progress and prospects: gene therapy clinical trials (part 2).
Review in Gene therapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Oncolytic Virotherapy in Solid Tumors: A Current Review.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025Review
- Role of gene therapy in treatment of cancer with craniofacial regeneration-current molecular strategies, future perspectives, and challenges: a narrative review.Journal of Yeungnam medical science · 2024Article
- Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic disease.American journal of medical genetics. Part C, Seminars in medical genetics · 2023Article
- Liver transplantation in rare late-onset ornithine transcarbamylase deficiency with central nervous system injury: A case report and review of the literature.Brain and behavior · 2022Review
- Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics.Advanced pharmaceutical bulletin · 2019Review
- Exosomes and their Application in Biomedical Field: Difficulties and Advantages.Molecular neurobiology · 2018Review
- Pressing diseases that represent promising targets for gene therapy.Discovery medicine · 2017Review
- Current status of non-viral gene therapy for CNS disorders.Expert opinion on drug delivery · 2016Review
- Review
- [Research advances on gene therapy for hemophilia A].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2015Article
- Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors.Journal of controlled release : official journal of the Controlled Release Society · 2014Article
- Genetic correction of stem cells in the treatment of inherited diseases and focus on xeroderma pigmentosum.International journal of molecular sciences · 2013Review
- Chitosan for gene delivery and orthopedic tissue engineering applications.Molecules (Basel, Switzerland) · 2013Review
- Design of hybrid lipid/retroviral-like particle gene delivery vectors.Molecular pharmaceutics · 2013Article
- Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.Journal of neuro-oncology · 2012Review
- Gene and cell therapy based treatment strategies for inflammatory bowel diseases.World journal of gastrointestinal pathophysiology · 2011Article
- Regulatory and ethical issues for phase I in utero gene transfer studies.Human gene therapy · 2011Article
- Downstream processing of cell culture-derived virus particles.Expert review of vaccines · 2011Review
- An adeno-associated virus vector efficiently and specifically transduces mouse skeletal muscle.Molecular biotechnology · 2011Article
- Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.Journal of controlled release : official journal of the Controlled Release Society · 2011Article
Corrections and comments
- Erratum issuedAlton, Eric [removed]; Ferrari, Stefano [removed]; Griesenbach, Uta [removed]; Aiuti, A [added]; Bachoud-Lévi, A C [added]; Blesch, A [added]; Brenner, M K [added]; Cattaneo, F [added]; Chiocca, E A [added]; Gao, G [added]; High, K A [added]; Leen, A M [a
Authors and funding
21 authors.
Funding
Abstract
This is the second part of a review summarizing progress and prospects in gene therapy clinical research. Twenty key diseases/strategies are succinctly described and commented on by leaders in the field. This part includes clinical trials for skin diseases, neurological disorders, HIV/AIDS, ornithine transcarbamylase deficiency, alpha(1)-antitrypsin deficiency, haemophilia and cancer.
Indexed as
Identifiers
17984995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.